Vimarsana
Biggest News Aggregation in the World

Page 2 - Novopen Echo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Novopen Echo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Novopen Echo Today - Breaking & Trending Today

Focused on diabetes, Eli Lilly inks integration deals with Roche, Dexcom, Glooko and more - Vimarsana News

Focused on diabetes, Eli Lilly inks integration deals with Roche, Dexcom, Glooko and more

Photo: Martin Barraud/Getty Images Pharma giant Eli Lilly has inked a series of deals with four diabetes management companies to integrate with its forthcoming Tempo Pen and Tempo Smart Button products. The companies that signed strategic international agreements with Eli Lilly are Dexcom, Glooko, myDiabby Healthcare and Roche. Through the agreements, Eli Lilly’s Tempo Pen and connected Tempo Smart Button will integrate with the software platforms and/or medical devices offered by the diabetes management companies to allow for the collection and sharing of personal health data. "We're pleas...

Insulin Pen Cap Market R & D including top key players The bee, Novopen Echo – KSU - Vimarsana News

Insulin Pen Cap Market R & D including top key players The bee, Novopen Echo – KSU

  Insulin Pen Cap Market Forecast 2029: Revenue, Size & Growth Global Insulin Pen Cap Market Forecast till 2029 research includes reliable ec

Roche's mySugr app to integrate with Novo Nordisk's smart insulin pens - Vimarsana News

Roche's mySugr app to integrate with Novo Nordisk's smart insulin pens

(Photo credit: mySugr)  Roche's diabetes management app mySugr's Logbook is now integrating with Novo Nordisk's connected insulin pens: the NovoPen 6 and NovoPen Echo Plus. Patients will be able connect the mySugr Logbook to their smart-pen device in order to create more data set and reports with more insights. According to the companies, the goal is to be able to share more insights with healthcare providers in order to guide disease management. This new effort comes after the Swiss pharma giant signed a collaboration deal with the diabetes company in 2019. WHY IT MATTERS Diabetes is a com...